Page last updated: 2024-08-26

bosentan anhydrous and lysophosphatidylcholines

bosentan anhydrous has been researched along with lysophosphatidylcholines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, N; Laher, I; MacLeod, KM; Rodrigues, B; So, J; Zhang, R	1

Other Studies

1 other study(ies) available for bosentan anhydrous and lysophosphatidylcholines

Article	Year
The ischemic metabolite lysophosphatidylcholine increases rat coronary arterial tone by endothelium-dependent mechanisms. Journal of molecular and cellular cardiology, 2009, Volume: 47, Issue:1 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antihypertensive Agents; Biological Factors; Blood Pressure; Bosentan; Coronary Vessels; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Lysophosphatidylcholines; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Sulfonamides; Vasoconstriction	2009

Article

Year

The ischemic metabolite lysophosphatidylcholine increases rat coronary arterial tone by endothelium-dependent mechanisms.

Journal of molecular and cellular cardiology, 2009, Volume: 47, Issue:1

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antihypertensive Agents; Biological Factors; Blood Pressure; Bosentan; Coronary Vessels; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Lysophosphatidylcholines; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Sulfonamides; Vasoconstriction

2009